Recombinant porcine factor VIII corrects thrombin generation in vitro in plasma from patients with congenital hemophilia A and inhibitors.
Research and practice in thrombosis and haemostasis
View this publicationResearch and practice in thrombosis and haemostasis
View this publicationFrontiers in immunology
View this publicationThe Journal of clinical endocrinology and metabolism
View this publicationInternational journal of pharmaceutics
View this publicationThe Journal of clinical investigation
View this publicationMicrobiome
View this publicationBlood advances
View this publicationJournal of the American Heart Association
View this publicationEMBO reports
View this publicationTrials
View this publication